LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1TAPI Technology & API Services
03 2Alembic Pharmaceuticals Limited
04 1Artis Biotech
05 1Beijing Mesochem Technology
06 1Beijing Sjar Technology Development
07 1Biotechnica DWC
08 1Epoch Labs
09 1Fresenius Kabi Oncology Limited
10 1Guangzhou Tosun Pharmaceutical
11 1Hangzhou Longshine Bio-Tech
12 2Hetero Drugs
13 1Lunan Pharmaceutical
14 1MSN Laboratories
15 1Mac-Chem Products (India) Pvt.Ltd
16 1Natco Pharma
17 1Ningbo Zhenlei Chemical Co.,Ltd
18 1Qilu Antibiotics Pharmaceutical Co., Ltd.
19 1Sakar Healthcare
20 1Shilpa Medicare
21 1Shouyuan Chemical
22 1Sun Pharmaceutical Industries Limited
23 1Teva Pharmaceutical Industries
24 1Vannsh Life Sciences
25 1Yangtze River Pharmaceutical Group
01 1Algeria
02 9China
03 14India
04 2Israel
05 1U.S.A
01 7Active
02 1Inactive
03 19Blank
01 27Blank
01 27Blank
01 1WC-0041
02 1WC-0041A3
03 1WC-0082
04 1WC-0082A8
05 1WC-0115A3
06 1WC-0349
07 21Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-28
Pay. Date : 2017-01-10
DMF Number : 31302
Submission : 2017-01-12
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-07-18
Pay. Date : 2017-06-27
DMF Number : 31848
Submission : 2017-06-30
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-02
Written Confirmation Number : WC-0082
Address of the Firm :
NDC Package Code : 46708-895
Start Marketing Date : 2017-06-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-06-29
Pay. Date : 2017-04-28
DMF Number : 31515
Submission : 2017-05-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30927
Submission : 2016-12-31
Status : Inactive
Type : II
Date of Issue : 2022-09-30
Valid Till : 2025-09-15
Written Confirmation Number : WC-0115A3
Address of the Firm :
Date of Issue : 2021-04-20
Valid Till : 2022-07-02
Written Confirmation Number : WC-0082A8
Address of the Firm :
NDC Package Code : 46708-895
Start Marketing Date : 2017-06-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
We have 25 companies offering Afatinib (diMaleate)
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?